GlassScriptPhysician profile
Matthew P Link
NPI 1912050113
$4,789.22
in general payments reported to CMS, 2019-2025
23 companies · $91.50 in 2025
The $91.50 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $1,303 · 2021: $1,969 · 2022: $256 · 2023: $415 · 2024: $457 · 2025: $91.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,626.00 | 2020-2021 | |
| Smith+Nephew, INC. | $788.37 | 2021-2025 | Evos, Trigen Intertan, Bone Anchors With Arthroscopic Delivery System |
| Horizon Therapeutics Plc | $514.31 | 2019-2022 | |
| Depuy Synthes Sales INC. | $161.91 | 2021-2025 | Orthovisc, Monovisc |
| Dynasplint Systems INC. | $103.14 | 2021 | |
| Fidia Pharma USA INC. | $99.48 | 2023-2025 | Hymovis, Triluron |
| Bsn Medical INC | $93.49 | 2019 | |
| Ermi LLC | $57.31 | 2019-2021 | |
| Baxter Healthcare | $53.58 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $46.19 | 2019-2022 | |
| Ethicon US, LLC | $29.43 | 2021 | |
| Daiichi Sankyo INC. | $24.56 | 2019 | |
| Convatec INC. | $22.87 | 2019 | |
| Heron Therapeutics, INC. | $21.21 | 2021 | |
| Davol INC. | $20.11 | 2023 | Arista Ah Flexitip |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.28 | 2024 | Krystexxa |
| Boston Scientific Corporation | $18.21 | 2022 | |
| Orthogenrx INC. | $17.76 | 2019 | |
| Vericel Corporation | $17.53 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $15.26 | 2025 | |
| Abbott Laboratories | $15.03 | 2022 | |
| Abbvie INC. | $13.44 | 2021 | |
| Kci USA, INC. | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Link listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.